Authors
Chinese Society of Hematology, Chinese Medical Association, Chinese College of Chest Physicians, Chinese Medical Doctor Association, Leukemia Committee, Chinese Society of Clinical Oncology, Immunodeficiency Committee, Guangdong Provincial Association of Basic Medicine, Guangdong Respiratory and Health Association, Committee of Hematological Immunology Diagnosis and Treatment, Guangdong Medical Education Association
Published in
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. Volume 47. Issue 8. Pages 721-738. Aug 14, 2026.
Abstract
Pulmonary chronic graft-versus-host disease (cGVHD) is a clinically significant complication after allogeneic hematopoietic stem cell transplantation, severely affecting the quality of life and survival rate of hematopoietic stem cell transplantation recipients. Bronchiolitis obliterans syndrome and interstitial lung diseases are the two main clinical entities. However, the insidious onset, diagnostic challenges, and limited therapeutic options of pulmonary cGVHD result in suboptimal clinical management and poor prognosis. Based on the latest developments in pulmonary cGVHD research and increasing evidence-based medicine data, this consensus was developed collaboratively by multidisciplinary experts domestically, providing recommendations for the early recognition, diagnosis, treatment, and management of pulmonary cGVHD, aiming to establish a standardized diagnostic and therapeutic workflow for pulmonary cGVHD applicable to clinical practice in China, to better guide clinical practice and improve patients' quality of life and survival rate.
PMID:
42851173
Bibliographic data and abstract were imported from PubMed on 09 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0